Clinical trial
Safety and Efficacy of Low-intensity Shockwave Therapy for Peyronie's Disease
NCT04821115 is registered in ClinicalTrials.gov with Hopital Foch as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Low-intensity Shockwave Therapy for Peyronie's Disease
- Lead sponsor
- Hopital Foch
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 6, 2021
- Completion date
- May 24, 2024
- Enrollment
- 120 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
penile diseases, peyronie disease